News & Updates

In the treatment of people with mild cognitive impairment, cilostazol is well tolerated but falls short of preventing further cognitive decline, according to the results of the phase II COMCID* trial.

Patients with amphetamine-induced psychosis (AIP) who have been treated with antipsychotics appear to have a longer length of stay (LOS) than those who did not receive such treatment, reports a study.

In a study presented at ESMO Asia 2023, tofacitinib, a rapidly acting JAK-STAT inhibitor with reported efficacy in the treatment of various autoimmune diseases, was effective for the management of difficult-to-treat immune-related adverse events (irAEs) and was well-tolerated in cancer patients, with only a few patients developing infectious events.

Injection with the novel, long-acting PCSK9 inhibitor recaticimab once every 3 months reduces LDL-cholesterol (LDL-C) levels by >50 percent compared with placebo in patients already maxed out on statins in the phase III REMAIN-2 trial.

Rabeprazole sodium EC tab 20 mg and Lyo powd for IV inj (vial + 5 mL amp diluent) 20 mg x 10 mL x 1’s.

Cefepime HCl Powd for inj 1 g

Telmisartan, amlodipine besilate 40 mg/5 mg, 40 mg/10 mg, 80 mg/5 mg and 80 mg/10 mg tablet